Updates to the Primary Care Guidelines for the Management of HIV/AIDS in Adults: Common Non-Infectious Co-Morbidities

This webinar will be presented by:

Dr. Marianne Harris, MD, CCFP
Clinical Assistant Professor, Department of Family Practice
Faculty of Medicine, University of British Columbia
Clinical Trials Physician, BC Centre for Excellence in HIV/AIDS

Following this webinar, participants will be able to:

  1. Explain why people living with HIV (PLWH) may be at risk of non-infectious co-morbid conditions, including:
  • cardiovascular disease
  • insulin resistance and diabetes mellitus
  • bone disease
  • renal disease
  • hypogonadism
  • neurocognitive impairment
  • lung disease
  • liver disease and cirrhosis
  • cancer
  • Outline the latest recommendations for screening and assessment of common non-infectious co-morbidities among PLWH
  • Apply some basic principles for preventing non-infectious co-morbidities in PLWH receiving antiretroviral therapy

    • The presentation will be followed by a question and answer period where participants will have the opportunity to ask questions and receive real time responses from the presenter.

    Cost: Free registration.

    Please register for the webinar by clicking the following link:

    click here.

    If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars

    This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credits.

    If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca.


    Event Details

    Days
    Hours
    Minutes
    Seconds
    Start Date
    • December 15, 2021 12:00
    End Date
    • December 15, 2021 13:00
    Email
    education@bccfe.ca
    Event Category
    • Learning Series
    Calendar of Events
    Click here for the Calendar of Events
    Attendees of the BC-CfE Learning Series will be able to:
    • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
    • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
    • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
    • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
    Scroll to Top

    During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

    • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
    • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
    • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

    During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

    The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
    For more details and example reports, please click on the button below

    Laboratory Order Forms

    Start typing and press enter to search